Patients with the rs118192170 TT genotype may have a decreased, but not absent, risk for malignant hyperthermia based on this variant when treated with volatile anesthetics (desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane) and/or succinylcholine as compared to patients with the CC or CT genotype. Other genetic or clinical factors may also influence the risk for malignant hyperthermia.,临床等位基因

Patients with the rs118192170 TT genotype may have a decreased, but not absent, risk for malignant hyperthermia based on this variant when treated with volatile anesthetics (desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane) and/or succinylcholine as compared to patients with the CC or CT genotype. Other genetic or clinical factors may also influence the risk for malignant hyperthermia.

临床注释ID

1183705788

基因型等位基因

TT

等位基因的功能